article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

Now that these innovations are here to stay (or so we hope), are we circling back to ensure adequate understanding of what is needed to achieve their full potential for public health improvement? She was the patient keynote speaker at DPHARM 2021 and is a HIMSS Digital Health Influencer.

BioTech 110
article thumbnail

FDA Gives Diabetes Treatments Low Priority

Insulin Nation

Even though health officials readily admit that diabetes is an urgent public health problem, a new diabetes medicine or device usually finds itself in ninth position on the FDA docket for a pre-market clearance. To understand why requires an understanding of the history of the FDA, and its limitations.